Federal Register notice: FDA withdraws approval of a new animal drug application at the sponsors request because the product is no longer manufactured...
Genentech says its Phase 3 study IMvigor211 that evaluated Tecentriq (atezolizumab) in people with locally advanced or metastatic urothelial cancer wh...
PhRMA adds research requirements to its membership criteria, dropping companies that dont spend enough on research and development of new therapies.
Researchers say a large-scale population study confirms anecdotal reports of ketamines effectiveness as an antidepressant.
Responding to the firing of FBI director James Comey, the Senate Health, Education, Labor, and Pensions Committee postpones a planned mark-up of a bil...
Federal Register notice: FDA announces the availability of draft revisions to the FDA Blueprint for Prescriber Education for Extended-Release and Long...
Friends of Cancer Research releases updated statistics showing that FDA reviews and approves cancer drugs faster than the European Medicines Agency.
FDA says reports that fluoroquinolones may result in retinal detachment, aortic aneurysm or aortic dissection are not supported by patient cases ident...